Preliminary Results of Utrasound-Guided Percutaneous Radiofrequency Ablation in the Treatment of Refractory Non-nodular Hyperthyroidism
CardioVascular and Interventional Radiology · 2023
DOI: 10.1007/s00270-023-03401-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift CardioVascular and Interventional Radiology, 2023. Verfasst von Tang Xiaoyin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Tumor Interventional Oncology, School of Medicine, Renji Hospital, Shanghai Jiaotong University, 160 Pujian Road, Shanghai, 200127, Chi…. Hauptthemen laut MEDLINE: Thyroid Nodule, Radiofrequency Ablation, Hyperthyroidism, Catheter Ablation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: To assess the safety and efficacy of ultrasound-guided percutaneous radiofrequency ablation (RFA) for the treatment of refractory non-nodular hyperthyroidism. METHODS: This was a single-center retrospective study in 9 patients with refractory non-nodular hyperthyroidism (2 males, 7 females; median age, range, 36 years, 14-55 years) who underwent RFA between August 2018 and September 2020. The incidence of post-procedural complications, changes in thyroid volume, thyroid function and the use and dosages of anti-thyroid drugs, were compared pre- and post-RFA. RESULTS: All patients completed the procedure successfully, and no serious complications occurred. Three months after ablation, thyroid volumes were significantly decreased with the mean volumes of the right and left lobes reduced to 45.6% (10.9 ± 2.2 ml/23.9 ± 7.2 ml, p < 0.001) and 50.2% (10.8 ± 7.4 ml/21.5 ± 11.4 ml, p = 0.001) of the volumes within 1 week after ablation. The thyroid function was gradually improved in all patients. At 3 months post-ablation, the levels of FT3 and FT4 were returned to the normal range (FT3, 4.9 ± 1.6 pmol/L vs. 8.7 ± 4.2 pmol/L, p = 0.009; FT4, 13.1 ± 7.2 pmol/L vs. 25.9 ± 12.6 pmol/L, p = 0.038), the TR-Ab level was significantly lower (4.8 ± 3.9 vs. 16.5 ± 16.4 IU/L, p = 0.027), and the TSH level was significantly higher (0.76 ± 0.88 vs. 0.03 ± 0.06, p = 0.031) than that before-ablation. Additionally, three months after RFA, the anti-thyroid medication dosages were reduced to 31.25% compared to baseline (p < 0.01). CONCLUSION: Ultrasound-guided RFA in the treatment of refractory non-nodular hyperthyroidism was safe and effective in this small group of patients with limited follow-up. Further studies with larger cohorts and longer follow-up are needed to validate this potential new application of thyroid thermal ablation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Tumor Interventional Oncology, School of Medicine, Renji Hospital, Shanghai Jiaotong University, 160 Pujian Road, Shanghai, 200127, China.
- Department of Anesthesiology, School of Medicine, Renji Hospital, Shanghai Jiaotong University, 160 Pujian Road, Shanghai, 200127, China.
- Department of Tumor Interventional Oncology, School of Medicine, Renji Hospital, Shanghai Jiaotong University, 160 Pujian Road, Shanghai, 200127, China. rjliping@126.com.
- Department of Tumor Interventional Oncology, School of Medicine, Renji Hospital, Shanghai Jiaotong University, 160 Pujian Road, Shanghai, 200127, China. zhaiboshi@sina.com.
Zitieren
APA
Xiaoyin, T., Bingwei, L., Min, D., Yan, L., Ping, L., & Bo, Z. (2023). Preliminary Results of Utrasound-Guided Percutaneous Radiofrequency Ablation in the Treatment of Refractory Non-nodular Hyperthyroidism. CardioVascular and Interventional Radiology. https://doi.org/10.1007/s00270-023-03401-5
Vancouver
Xiaoyin T, Bingwei L, Min D, Yan L, Ping L, Bo Z. Preliminary Results of Utrasound-Guided Percutaneous Radiofrequency Ablation in the Treatment of Refractory Non-nodular Hyperthyroidism. CardioVascular and Interventional Radiology. 2023. doi:10.1007/s00270-023-03401-5
BibTeX
@article{Xiaoyin2023,
author = {Xiaoyin, Tang and Bingwei, Lu and Min, Ding and Yan, Lin and Ping, Li and Bo, Zhai},
title = {Preliminary Results of Utrasound-Guided Percutaneous Radiofrequency Ablation in the Treatment of Refractory Non-nodular Hyperthyroidism},
journal = {CardioVascular and Interventional Radiology},
year = {2023},
doi = {10.1007/s00270-023-03401-5}
}
EUVIMED